Trial Information
A Phase 1/2a Study of BMS-986253 in Combination with Nivolumab in Advanced Cancers (CA027002)
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at
877-664-7724
A Phase 1/2a Study of BMS-986253 in Combination with Nivolumab in Advanced Cancers (CA027002)
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at
877-664-7724
View our locations on map!